BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15534571)

  • 1. Complications of the intrauterine device in nulliparous and parous women.
    Veldhuis HM; Vos AG; Lagro-Janssen AL
    Eur J Gen Pract; 2004 Sep; 10(3):82-7. PubMed ID: 15534571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the use of intrauterine devices in nulliparous women.
    Graham S; Simcock BW
    Contraception; 1982 Oct; 26(4):323-46. PubMed ID: 6759026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modern intra-uterine devices.
    Odlind V
    Baillieres Clin Obstet Gynaecol; 1996 Apr; 10(1):55-67. PubMed ID: 8736722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices.
    Aoun J; Dines VA; Stovall DW; Mete M; Nelson CB; Gomez-Lobo V
    Obstet Gynecol; 2014 Mar; 123(3):585-592. PubMed ID: 24499755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of intrauterine contraceptive devices in nulliparous women: personal experience over a 12-year period.
    Lete I; Morales P; de Pablo JL
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):190-3. PubMed ID: 10036601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of age and parity with intrauterine device expulsion.
    Madden T; McNicholas C; Zhao Q; Secura GM; Eisenberg DL; Peipert JF
    Obstet Gynecol; 2014 Oct; 124(4):718-726. PubMed ID: 25198262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine contraceptive device and pelvic inflammatory disease.
    Toivonen J
    Ann Med; 1993 Apr; 25(2):171-3. PubMed ID: 8489756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intrauterine devices in nulliparous women.
    Lohr PA; Lyus R; Prager S
    Contraception; 2017 Jun; 95(6):529-537. PubMed ID: 27591814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrauterine contraception: the role of general practitioners in four Dutch general practices.
    Vos AA; Veldhuis HM; Lagro-Janssen TL
    Contraception; 2004 Apr; 69(4):283-7. PubMed ID: 15033402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil.
    Lassner KJ; Chen CH; Kropsch LA; Oberle MW; Lopes IM; Morris L
    Bull Pan Am Health Organ; 1995 Sep; 29(3):206-15. PubMed ID: 8520606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adolescent experience with intrauterine device insertion and use: a retrospective cohort study.
    Bayer LL; Jensen JT; Li H; Nichols MD; Bednarek PH
    Contraception; 2012 Nov; 86(5):443-51. PubMed ID: 22560185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Copper IUDs, PID, and fertility in nulliparous women.
    Struthers BJ
    Adv Contracept; 1991; 7(2-3):211-30. PubMed ID: 1950720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Return to fertility in nulliparous and parous women after removal of the GyneFix intrauterine contraceptive system.
    Delbarge W; Bátár I; Bafort M; Bonnivert J; Colmant C; Dhont M; Fonzé V; Gevers R; Janssens D; Lavalley P; Salmin E; Degueldre M; Vrijens M; Van Kets H; Wildemeersch D
    Eur J Contracept Reprod Health Care; 2002 Mar; 7(1):24-30. PubMed ID: 12041861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care provider attitudes and practices related to intrauterine devices for nulliparous women.
    Tyler CP; Whiteman MK; Zapata LB; Curtis KM; Hillis SD; Marchbanks PA
    Obstet Gynecol; 2012 Apr; 119(4):762-71. PubMed ID: 22433340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The acceptability of using IUDs among Egyptian nulliparous women: a cross-sectional study.
    Elkhateeb RR; Kishk E; Sanad A; Bahaa H; Hagazy AR; Shaheen K; Moustafa E; Fares H; Gomaa K; Mahran A
    BMC Womens Health; 2020 Jun; 20(1):117. PubMed ID: 32503576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.